CoChat

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lym‐phocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte‐specific telomere shortening correlated with senescence‐associated p‐galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type‐specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.—Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 16, 935–942 (2002)

Overview

Integrity signals

Registry

Crossref · 10.1096/fj.01-0977com

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Rudolph K. L., 2001, Telomeres and telomerase in experimental liver cirrhosis, The Liver Biology and Pathobiology, 1000

Cited by

Items 201–300 of 547

Metadata

Authors
WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., & RUDOLPH, K. L.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • Department of Gastroenterology, Hepatology, and Endocrinology Medical School Hannover Germany
  • Consejo Superior de Investigaciones Científicas (ES)
  • Department of Immunology and Oncology Centro National de Biotecnologia/CSIC Madrid Spain
Venue
The FASEB Journal
Publisher
Wiley
Published
2002-07
Volume
16
Issue
9
Pages
935-942
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2166704790
Cited by
527
References
34
Citations by year
2026: 4 · 2025: 15 · 2024: 22 · 2023: 23 · 2022: 20 · 2021: 28 · 2020: 35 · 2019: 17 · 2018: 29 · 2017: 22 · 2016: 24 · 2015: 18 · 2014: 30 · 2013: 20 · 2012: 20
FWCI
7.61
Type
journal article
Language
en
Open access
closed
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (Ru 745/2-1, SFB 265/C5)
  • Deutsche Krebshilfe (10-1809-Ru1)
  • Ministerio de Ciencia y Tecnología
  • European Commission
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
telomere shortening, hepatocyte senescence, liver cirrhosis, liver fibrosis, senescence-associated β-galactosidase, hepatocytes, hepatic stellate cells, lymphocytes, telomere length, cirrhosis progression, regenerative capacity, aging
MeSH terms
Adolescent, Adult, Age Factors, Aged, beta-Galactosidase, Child, Humans, Liver Cirrhosis, Middle Aged, Models, Biological, Biomarkers, Telomere, Cellular Senescence, Disease Progression, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.